JiangSu WuZhong Pharmaceutical Development Co., Ltd.

SHSE:600200 Stock Report

Market Cap: CN¥7.0b

JiangSu WuZhong Pharmaceutical Development Balance Sheet Health

Financial Health criteria checks 5/6

JiangSu WuZhong Pharmaceutical Development has a total shareholder equity of CN¥1.9B and total debt of CN¥1.7B, which brings its debt-to-equity ratio to 93.1%. Its total assets and total liabilities are CN¥4.1B and CN¥2.3B respectively. JiangSu WuZhong Pharmaceutical Development's EBIT is CN¥32.4M making its interest coverage ratio 0.5. It has cash and short-term investments of CN¥1.4B.

Key information

93.1%

Debt to equity ratio

CN¥1.73b

Debt

Interest coverage ratio0.5x
CashCN¥1.41b
EquityCN¥1.86b
Total liabilitiesCN¥2.27b
Total assetsCN¥4.13b

Recent financial health updates

Recent updates

Health Check: How Prudently Does JiangSu WuZhong Pharmaceutical Development (SHSE:600200) Use Debt?

Sep 25
Health Check: How Prudently Does JiangSu WuZhong Pharmaceutical Development (SHSE:600200) Use Debt?

Sentiment Still Eluding JiangSu WuZhong Pharmaceutical Development Co., Ltd. (SHSE:600200)

Jul 31
Sentiment Still Eluding JiangSu WuZhong Pharmaceutical Development Co., Ltd. (SHSE:600200)

JiangSu WuZhong Pharmaceutical Development (SHSE:600200) Is Making Moderate Use Of Debt

Jun 06
JiangSu WuZhong Pharmaceutical Development (SHSE:600200) Is Making Moderate Use Of Debt

Many Still Looking Away From JiangSu WuZhong Pharmaceutical Development Co., Ltd. (SHSE:600200)

Mar 12
Many Still Looking Away From JiangSu WuZhong Pharmaceutical Development Co., Ltd. (SHSE:600200)

Financial Position Analysis

Short Term Liabilities: 600200's short term assets (CN¥2.9B) exceed its short term liabilities (CN¥2.0B).

Long Term Liabilities: 600200's short term assets (CN¥2.9B) exceed its long term liabilities (CN¥313.0M).


Debt to Equity History and Analysis

Debt Level: 600200's net debt to equity ratio (17.1%) is considered satisfactory.

Reducing Debt: 600200's debt to equity ratio has increased from 41.3% to 93.1% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: 600200 has sufficient cash runway for more than 3 years based on its current free cash flow.

Forecast Cash Runway: 600200 has sufficient cash runway for more than 3 years if free cash flow continues to reduce at historical rates of 4.1% each year


Discover healthy companies